Live feed07:00:00·106dPRReleaseRezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor HyperinsulinismRZLT· Rezolute Inc.Health CareOriginal source
